Clinical trial
A Phase II Trial for the Treatment of POEMS Syndrome With Daratumumab
NCT04396496 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial for the Treatment of POEMS Syndrome With Daratumumab
- Lead sponsor
- University of Arkansas
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 22, 2020
- Completion date
- October 16, 2023
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.